FTMI-TBPET-PSMR 2026 Valencia

Session

Session 8: FTMI-Systems

12 May 2026, 17:00

Valencia Hotel Las Arenas

Conveners

Session 8: FTMI-Systems

• Kuangyu Shi

13. Time-of-Flight Artefact Reduction in Limited-Angle PET: How Effective is it in Practice?

Dr Dennis Schaart

12/05/2026, 17:00

Limited-angle positron emission tomography (PET) is attracting increasing interest for a variety of applications, such as organ-specific PET, in-vivo verification in particle therapy, and cost-effective total-body PET (TB-PET). Various simulation studies have indicated that the artefacts that arise in limited-angle PET images due to missing lines-of-response (LOR) can be mitigated by means of...

35. Improvements in Compton camera prototypes for targeted radionuclide therapy

Prof. Gabriela Llosá (IFIC, CSIC-UV)

12/05/2026, 17:20

Compton cameras show promise in medical applications in which the performance of gamma cameras is not optimal. This is the case of Targeted Radionuclide Therapy (TRT) assessment, which is gaining interest as a cancer treatment option. In this treatment modality, secondary photon emission from the therapeutic radionuclides can be employed to image the radiopharmaceutical distribution in the...

64. Prototype Development of an On-Chip PET System with Dual-Sided Crystal Readout for Enhanced Gamma-Ray Interaction Point Localization

Narendra Rathod (Inselspital and University of Bern)

12/05/2026, 17:40

Background. Organ-on-chip (OOC) platforms mimic human tissue at millimeter scale and provide unique models for drug development and disease research. Quantitative imaging of radiotracer distribution within these devices can totally change their scientific utility, however no PET system exists at the physical scale and resolution required. We present a dedicated on-chip PET detector concept....

37. The ADMIRAL experiment: Ag-111 for imaging and therapy

Alberto Arzenton (University of Padua), Aurora Leso (University of Ferrara), Davide Serafini (INFN-LNL), EMILIO MARIOTTI (Università di Siena), Giulia Saveria Valli (University of Siena), Marcello Lunardon (University of Padova), Stefano Corradetti, alberto andrighetto (INFN-LNL)

12/05/2026, 18:00

The ISOLPHARM (ISOL technique for radioPHARMaceuticals) project, led by the Legnaro National Laboratories of the National Institute of Nuclear Physics, aims to produce a wide range of high-purity radioisotopes for medical applications, both diagnostic and therapeutic. A central role is played by SPES (Selective Production of Exotic Species), a second-generation ISOL facility that enables the...